High heart rate amplifies the risk of cardiovascular mortality associated with elevated uric acid.

AIMS Whether the association between uric acid (UA) and cardiovascular disease is influenced by some facilitating factors is unclear. The aim of this study was to investigate whether the risk of cardiovascular mortality (CVM) associated with elevated UA was modulated by the level of resting heart rate (HR). METHODS AND RESULTS  Multivariable Cox analyses were made in 19 128 participants from the multicentre Uric acid Right for heArt Health study. During a median follow-up of 11.2 years, there were 1381 cases of CVM. In multivariable Cox models both UA and HR, either considered as continuous or categorical variables were independent predictors of CVM both improving risk discrimination (P ≤ 0.003) and reclassification (P < 0.0001) over a multivariable model. However, the risk of CVM related to high UA (≥5.5 mg/dL, top tertile) was much lower in the subjects with HR <median [71.3 b.p.m., adjusted hazard ratio 1.38, 95% confidence interval (CI) 1.20-1.59] than in those with HR ≥median [2.09 (95% CI 1.75-2.51)]. In the participants stratified by HR tertile, the risk related to hyperuricaemia was 2.38 (95% CI 1.82-3.10) in people with HR ≥76 b.p.m. and was 1.24 (95% CI 0.92-1.67) in those with HR <66 b.p.m. Similar results were obtained in the hypertensive patients, in the participants ≥65 years, and in the subjects not taking beta-blockers. CONCLUSION This data suggest that the contribution of UA to determining CVM is modulated by the level of HR supporting the hypothesis that activation of the sympathetic nervous system facilitates the action of UA as a cardiovascular risk factor.

[1]  M. Piepoli,et al.  Role of comorbidities in heart failure prognosis Part 2: Chronic kidney disease, elevated serum uric acid , 2020, European journal of preventive cardiology.

[2]  G. Grassi,et al.  The Complex Relationship Between Serum Uric Acid, Endothelial Function and Small Vessel Remodeling in Humans , 2020, Journal of clinical medicine.

[3]  Blair D. Johnson,et al.  High Fructose Corn Syrup Sweetened Soft Drink Consumption Increases Vascular Resistance in the Kidneys at Rest and during Sympathetic Activation. , 2020, American journal of physiology. Renal physiology.

[4]  G. Jennings,et al.  Evaluation of elevated heart rate as a sympathetic nervous system biomarker in essential hypertension. , 2020, Journal of hypertension.

[5]  G. Parati,et al.  Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years , 2019, Hypertension.

[6]  Thomas Kahan,et al.  2018 ESC/ESH Guidelines for the management of arterial hypertension. , 2018, European heart journal.

[7]  L. Polito,et al.  The role of xanthine oxidoreductase and uric acid in metabolic syndrome. , 2018, Biochimica et biophysica acta. Molecular basis of disease.

[8]  G. Sesti,et al.  Higher serum levels of uric acid are associated with a reduced insulin clearance in non-diabetic individuals , 2018, Acta Diabetologica.

[9]  P. Dagnelie,et al.  Uric acid and blood pressure: exploring the role of uric acid production in The Maastricht Study , 2017, Journal of hypertension.

[10]  E. Casiglia,et al.  Regular physical activity prevents development of hypertension in young people with hyperuricemia , 2017, Journal of hypertension.

[11]  E. Mathiesen,et al.  Resting heart rate trajectories and myocardial infarction, atrial fibrillation, ischaemic stroke and death in the general population: The Tromsø Study , 2017, European journal of preventive cardiology.

[12]  K. Kunikullaya,et al.  Correlation of serum uric acid with heart rate variability in hypertension. , 2015, Hipertension y riesgo vascular.

[13]  L. Afonso,et al.  Uric acid and cardiovascular disease risk reclassification: Findings from NHANES III , 2015, European journal of preventive cardiology.

[14]  C. Hsiung,et al.  Attenuating the mortality risk of high serum uric acid: the role of physical activity underused , 2014, Annals of the rheumatic diseases.

[15]  P. Puddu,et al.  Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications. , 2012, Journal of cardiology.

[16]  Lloyd E Chambless,et al.  Several methods to assess improvement in risk prediction models: Extension to survival analysis , 2011, Statistics in medicine.

[17]  Ewout W Steyerberg,et al.  Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers , 2011, Statistics in medicine.

[18]  Kuan-Hung Lin,et al.  Uric acid and the development of hypertension. , 2010, Medical science monitor : international medical journal of experimental and clinical research.

[19]  I. Holme,et al.  Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417 734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS) , 2009, Journal of internal medicine.

[20]  C. Scavone,et al.  Effects of isoproterenol treatment for 7 days on inflammatory mediators in the rat aorta. , 2008, American journal of physiology. Heart and circulatory physiology.

[21]  D. Mikhailidis,et al.  Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms. , 2008, International journal of cardiology.

[22]  C. Meisinger,et al.  Uric Acid Levels Are Associated With All-Cause and Cardiovascular Disease Mortality Independent of Systemic Inflammation in Men From the General Population: The MONICA/KORA Cohort Study , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[23]  J. Klenk,et al.  Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men. , 2008, Clinical chemistry.

[24]  C. Scavone,et al.  Changes in vascular reactivity following administration of isoproterenol for 1 week: a role for endothelial modulation , 2006, British journal of pharmacology.

[25]  J. Danesh,et al.  Serum Uric Acid and Coronary Heart Disease in 9,458 Incident Cases and 155,084 Controls: Prospective Study and Meta-Analysis , 2005, PLoS medicine.

[26]  P. Palatini,et al.  Relationship of plasma renin activity with caffeine intake and physical training in mild hypertensive men , 1996, European Journal of Epidemiology.

[27]  G. Eknoyan,et al.  National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification , 2003, Annals of Internal Medicine.

[28]  P Salmon,et al.  Effects of physical exercise on anxiety, depression, and sensitivity to stress: a unifying theory. , 2001, Clinical psychology review.

[29]  G Mancia,et al.  Heart rate as marker of sympathetic activity , 1998, Journal of hypertension.

[30]  S. Julius,et al.  Heart rate and the cardiovascular risk , 1997, Journal of hypertension.

[31]  G. Reaven,et al.  Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. , 1996, The New England journal of medicine.

[32]  D. Crews,et al.  A meta-analytic review of aerobic fitness and reactivity to psychosocial stressors. , 1987, Medicine and science in sports and exercise.

[33]  W. N. Kelley,et al.  Studies on the mechanism of fructose-induced hyperuricemia in man. , 1972, Metabolism: clinical and experimental.